Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hormones and endocrine disruptors in human seminal plasma

R. Hampl, J. Kubatova, J. Heracek, V. Sobotka, L. Starka

. 2013 ; 47 (3) : 149-158.

Language English Country Slovakia

Document type Research Support, Non-U.S. Gov't, Review

Grant support
NT13369 MZ0 CEP Register

Seminal plasma represents a unique environment for maturation, nutrition, and protection of male germ cells from damaging agents. It contains an array of organic as well as inorganic chemicals, encompassing a number of biologically and immunologically active compounds, including hormones. Seminal plasma contains also various pollutants transferred from outer environment known as endocrine disruptors. They interfere with hormones at the receptor level, act as inhibitors of their biosynthesis, and affect hormone regulation. In this minireview, the main groups of hormones detected in seminal plasma are summarized. Seminal gonadal steroids were investigated mostly with aim to use them as biomarkers of impaired spermatogenesis (sperm count, motility, morphology). Concentrations of hormones in the seminal plasma often differ considerably from the blood plasma levels in dependence on their origin. In some instances (dihydrotestosterone, estradiol), their informative value is higher than determination in blood. Out of peptide hormones detected in seminal plasma, peptides of transforming growth factor beta family, especially antimullerian hormone, and oligopeptides related to thyrotropin releasing hormone have the high informative value, while assessment of seminal gonadotropins and prolactin does not bring advantage over determination in blood. Though there is a large body of information about the endocrine disruptors’ impact on male reproduction, especially with their potential role in decline of male reproductive functions within the last decades, there are only scarce reports on their presence in seminal plasma. Herein, the main groups of endocrine disruptors found in seminal plasma are reviewed, and the use of their determination for investigation of fertility disorders is discussed.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19002200
003      
CZ-PrNML
005      
20190827134149.0
007      
ta
008      
190111s2013 xo f 000 0|eng||
009      
AR
024    0_
$a 10.4149/endo_2013_03_149 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xo
100    1_
$a Hampl, Richard, $d 1941- $7 jo20000074077 $u Institute of Endocrinology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Hormones and endocrine disruptors in human seminal plasma / $c R. Hampl, J. Kubatova, J. Heracek, V. Sobotka, L. Starka
504    __
$a Literatura
520    3_
$a Seminal plasma represents a unique environment for maturation, nutrition, and protection of male germ cells from damaging agents. It contains an array of organic as well as inorganic chemicals, encompassing a number of biologically and immunologically active compounds, including hormones. Seminal plasma contains also various pollutants transferred from outer environment known as endocrine disruptors. They interfere with hormones at the receptor level, act as inhibitors of their biosynthesis, and affect hormone regulation. In this minireview, the main groups of hormones detected in seminal plasma are summarized. Seminal gonadal steroids were investigated mostly with aim to use them as biomarkers of impaired spermatogenesis (sperm count, motility, morphology). Concentrations of hormones in the seminal plasma often differ considerably from the blood plasma levels in dependence on their origin. In some instances (dihydrotestosterone, estradiol), their informative value is higher than determination in blood. Out of peptide hormones detected in seminal plasma, peptides of transforming growth factor beta family, especially antimullerian hormone, and oligopeptides related to thyrotropin releasing hormone have the high informative value, while assessment of seminal gonadotropins and prolactin does not bring advantage over determination in blood. Though there is a large body of information about the endocrine disruptors’ impact on male reproduction, especially with their potential role in decline of male reproductive functions within the last decades, there are only scarce reports on their presence in seminal plasma. Herein, the main groups of endocrine disruptors found in seminal plasma are reviewed, and the use of their determination for investigation of fertility disorders is discussed.
650    12
$a endokrinní disruptory $x analýza $x farmakologie $x metabolismus $7 D052244
650    _2
$a fertilita $x účinky léků $7 D005298
650    12
$a hormony $x analýza $x metabolismus $7 D006728
650    12
$a sperma $x chemie $x metabolismus $7 D012661
650    _2
$a somatomediny $x analýza $x metabolismus $7 D013002
650    _2
$a transformující růstový faktor beta $x analýza $x metabolismus $7 D016212
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Vítků, Jana $7 xx0211876 $u Institute of Endocrinology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Heráček, Jiří, $d 1969- $7 nlk20050170272 $u Department of Urology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Sobotka, Vladimír, $d 1953- $7 xx0071044 $u Department of Urology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Stárka, Luboslav, $d 1930- $7 jn19990209795 $u Institute of Endocrinology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$t Endocrine regulations $x 1210-0668 $g Roč. 47, č. 3 (2013), s. 149-158 $w MED00001518
856    41
$u http://www.elis.sk/ $y stránka časopisu
910    __
$a ABA008 $b A 3699 $c 152 a $y 4 $z 0
990    __
$a 20190111122124 $b ABA008
991    __
$a 20190827134410 $b ABA008
999    __
$a ok $b bmc $g 1366537 $s 1040333
BAS    __
$a 3
BMC    __
$a 2013 $b 47 $c 3 $d 149-158 $i 1210-0668 $m Endocrine regulations $x MED00001518
GRA    __
$a NT13369 $p MZ0
LZP    __
$c NLK182 $d 20190218 $a NLK 2019-04/pk

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...